• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国大龄青少年和年轻成年人中B型脑膜炎球菌疫苗联合接种情况及潜在的疫苗接种错失机会:一项回顾性索赔数据库分析

Meningococcal B vaccine co-administration in older adolescents and young adults and potential missed opportunities for vaccination in the United States: a retrospective claims database analysis.

作者信息

Herrera-Restrepo Oscar, Multani Jasjit K, Zhou Zifan, Paltanwale Queenie, Olaiya Tosin, Coutinho Anna D, Shah Rajeev B, Chen Chi-Chang

机构信息

GSK, Philadelphia, PA, USA.

IQVIA, Falls Church, VA, USA.

出版信息

Curr Med Res Opin. 2025 Jul 6:1-13. doi: 10.1080/03007995.2025.2522806.

DOI:10.1080/03007995.2025.2522806
PMID:40553076
Abstract

BACKGROUND

In the United States (US), meningococcal serogroup B (MenB) vaccination is currently recommended under shared clinical decision-making for 16-23-year-olds to prevent invasive meningococcal disease; the MenB vaccine may be co-administered with other vaccines recommended for this age group.

RESEARCH DESIGN AND METHODS

A retrospective analysis of two US health insurance claims databases was conducted to estimate the proportion of commercially insured and Medicaid-insured 16-23-year-olds with potential missed opportunities for MenB vaccine series initiation co-administration. Potential missed opportunities were defined as visits with healthcare providers during which other recommended vaccines (MenACWY, Tdap, HPV, influenza, and/or COVID-19) were administered, but not the initial MenB vaccine dose.

RESULTS

In 2022, 74.5% of commercially insured and 67.1% of Medicaid-insured 16-23-year-olds had potential missed opportunities for MenB vaccination initiation co-administration. The proportion of missed opportunities was higher among 19-23-year-olds (versus 16-18-year-olds) and lower for visits with pediatricians (versus internists or general practitioners/family physicians). The most frequently co-administered vaccine was the MenACWY vaccine.

CONCLUSIONS

Many 16-23-year-olds had potential missed opportunities for MenB series initiation co-administration. Increasing awareness of the opportunity to initiate the MenB series co-administration may improve meningococcal vaccination coverage in the US.

摘要

背景

在美国,目前建议在共同临床决策下,为16至23岁人群接种B群脑膜炎球菌疫苗(MenB)以预防侵袭性脑膜炎球菌病;MenB疫苗可与该年龄组推荐的其他疫苗同时接种。

研究设计与方法

对两个美国医疗保险理赔数据库进行回顾性分析,以估计商业保险和医疗补助保险覆盖的16至23岁人群中,MenB疫苗系列起始接种或同时接种可能错失机会的比例。可能错失的机会定义为在与医疗服务提供者就诊期间,接种了其他推荐疫苗(A、C、W、Y群脑膜炎球菌结合疫苗、破伤风类毒素、白喉类毒素和无细胞百日咳疫苗、人乳头瘤病毒疫苗、流感疫苗和/或新冠疫苗),但未接种MenB疫苗首剂。

结果

2022年,74.5%的商业保险覆盖和67.1%的医疗补助保险覆盖的16至23岁人群有MenB疫苗起始接种或同时接种的潜在错失机会。19至23岁人群(相对于16至18岁人群)错失机会的比例更高,而与儿科医生就诊(相对于内科医生或全科医生/家庭医生)时错失机会的比例更低。最常同时接种的疫苗是A、C、W、Y群脑膜炎球菌结合疫苗。

结论

许多16至23岁人群有MenB疫苗系列起始接种或同时接种的潜在错失机会。提高对MenB系列起始接种或同时接种机会的认识,可能会提高美国的脑膜炎球菌疫苗接种覆盖率。

相似文献

1
Meningococcal B vaccine co-administration in older adolescents and young adults and potential missed opportunities for vaccination in the United States: a retrospective claims database analysis.美国大龄青少年和年轻成年人中B型脑膜炎球菌疫苗联合接种情况及潜在的疫苗接种错失机会:一项回顾性索赔数据库分析
Curr Med Res Opin. 2025 Jul 6:1-13. doi: 10.1080/03007995.2025.2522806.
2
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine targeting serogroups A, C, W, Y, and X when co-administered with routine childhood vaccines at ages 9 months and 15 months in Mali: a single-centre, double-blind, randomised, controlled, phase 3, non-inferiority trial.在马里,9月龄和15月龄儿童五价脑膜炎球菌结合疫苗(针对A、C、W、Y和X血清群)与常规儿童疫苗同时接种时的安全性和免疫原性:一项单中心、双盲、随机、对照、3期、非劣效性试验。
Lancet. 2025 Mar 29;405(10484):1069-1080. doi: 10.1016/S0140-6736(25)00046-7. Epub 2025 Mar 11.
3
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 study.在印度成年人中,五价脑膜炎球菌结合疫苗与四价脑膜炎球菌结合疫苗的安全性和免疫原性:一项观察者盲法、随机、活性对照、2/3期研究。
Lancet Infect Dis. 2025 Apr;25(4):399-410. doi: 10.1016/S1473-3099(24)00576-0. Epub 2024 Nov 6.
4
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.肺炎球菌结合疫苗的免疫原性和血清效力:系统评价和网络荟萃分析。
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.
5
Sexual Harassment and Prevention Training性骚扰与预防培训
6
Exploring meningococcal serogroup B vaccination conversations under shared clinical decision-making in the US.探讨美国共同临床决策下脑膜炎球菌 B 型疫苗接种对话。
Curr Med Res Opin. 2024 Jul;40(7):1253-1263. doi: 10.1080/03007995.2024.2362924. Epub 2024 Jun 14.
7
Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination.通过接种疫苗预防美国青少年和青年的脑膜炎球菌病。
Infect Dis Ther. 2025 Jun 3. doi: 10.1007/s40121-025-01166-7.
8
Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis.美国 B 型脑膜炎球菌疫苗系列接种启动:真实世界的理赔数据分析。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2165382. doi: 10.1080/21645515.2023.2165382. Epub 2023 Jan 30.
9
Awareness, attitudes, and practices on meningococcal serogroup B vaccination in the United States among parents of older adolescents and among young adults.美国青少年父母和年轻成年人对脑膜炎 B 型疫苗接种的意识、态度和实践。
Curr Med Res Opin. 2024 Jan;40(1):125-140. doi: 10.1080/03007995.2023.2285366. Epub 2024 Jan 3.
10
Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomised trial.五价脑膜炎球菌 ABCWY 疫苗在青少年和年轻成人中的免疫原性和安全性:一项观察者盲法、主动对照、随机试验。
Lancet Infect Dis. 2023 Dec;23(12):1370-1382. doi: 10.1016/S1473-3099(23)00191-3. Epub 2023 Aug 11.